A detailed history of Clear Harbor Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 599 shares of LLY stock, worth $542,322. This represents 0.04% of its overall portfolio holdings.

Number of Shares
599
Previous 622 3.7%
Holding current value
$542,322
Previous $362,000 28.45%
% of portfolio
0.04%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $13,620 - $18,222
-23 Reduced 3.7%
599 $465,000
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $326,668 - $385,098
622 New
622 $362,000
Q4 2020

Feb 04, 2021

SELL
$130.46 - $172.63 $48,531 - $64,218
-372 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$146.22 - $169.13 $54,393 - $62,916
372 New
372 $55,000
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $44,286 - $54,814
-372 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$106.92 - $132.43 $39,774 - $49,263
372 New
372 $48,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.